Osteochondrosis: Pathogenetic Bioregulatory Limitations of Using the Drug Discus Compositum
Journal Title: Біль. Суглоби. Хребет - Year 2016, Vol 2, Issue 22
Abstract
Treatment of osteochondrosis is one of the actual problems in the therapy of degenerative-dystrophic diseases of the musculoskeletal system [1]. The clinical studies have shown that osteochondrosis — a disease of the whole body, and therefore, interdisciplinary problem, relevant both for neurologists, as well as for orthopedists and general practitioners [2]. A brief review of clinical studies is presented demonstrating the relevance of using bioregulatory approach, Discus compositum and other combined bioregulatory drugs (CBD) [3–6]. The feature of CBD — the content of ultra-low doses (low dose, very-low dose antigen) of active substances that contribute to the recovery of the processes of self-regulation and detoxification in the body, activation of metabolism and regeneration/reparation processes. Bioregulatory action of CBD complements the effect of other medicines, combining well with them. Since the ultra-small doses are not metabolized in the body, CBD have no pharmacokinetics: they do not require additional energy and do not have a pharmacological stress on the body [3–6]. In this regard, they are well-tolerated by patients during chronic administration. Also, their application is helpful, if there are contraindications, side effects and the risk of complications when using other groups of drugs.
Authors and Affiliations
L. О. Vakulenko, S. V. Popovych
Keywords
Related Articles
- EP ID EP209365
- DOI 10.22141/2224-1507.2.22.2016.75761
- Views 97
- Downloads 0
Vitamin D and Iodine Deficiency:Impact on Health and Aging
The article is a review of the key highlights of the conference on Vitamin D and Iodine Deficiency, which took place on 21–22 of April in Chernivtsy (Ukraine). Data about status of Vitamin D in Ukrainian population, impa...
Dysmobility syndrome: a paradigm shift in fracture prevention
Fragility fractures engender major healthcare cost, reduce independence/quality and life and increase mortality risk. Despite availability of multiple therapies to reduce risk for future fracture, few patients are treate...
Vitamin D status in patients with nontraumatic transient loss of consciousness (literature review)
Vitamin D status in patients with nontraumatic transient loss of consciousness (literature review)
Clinical Case of Pseudarthrosis of the Tibia in Patient with Neurofibromatosis Type I
The article describes the clinical signs of neurofibromatosis type I, in particular its bone manifestations. Also information on current approaches to diagnosis and surgical treatment of patients with neurofibromatosis t...
Vitamin D and osteoarthritis
The attention of researchers and clinicians is drawn to vitamin D. It is a steroid hormone with a pluripotent mechanism of action, the targets of which, along with other organs and tissues, are articular cartilage and bo...